LEICA MICROSYSTEMS CMS GMBH

Their core work

Leica Microsystems is a major German manufacturer of precision optical instruments, specializing in microscopy systems for life sciences, materials science, and industrial applications. Within H2020, they contribute advanced imaging hardware and expertise — light sheet microscopy, multiphoton imaging, and spectroscopy platforms — to research consortia studying biological processes. Their role is that of a technology provider, supplying and adapting high-end imaging equipment that enables partners to visualize everything from cardiac development in zebrafish to cell tracking in kidney disease models.

What they specialise in

How they've shifted over time

Early projects (2017) centered on established techniques like light sheet microscopy and optical tweezers for biological imaging, particularly cardiac development research. By 2018-2019, the focus shifted toward more advanced modalities — multimodal imaging with near-infrared dyes, cell tracking nanoparticles, nonlinear optics, and vibrational microscopy. This progression reflects a move from single-modality biological imaging toward integrated, multi-technique platforms that combine spectroscopy with microscopy.

Leica is expanding from traditional optical microscopy into multiphoton and spectroscopic imaging, positioning itself for projects that require combined imaging-spectroscopy workflows in biomedical research.

How they like to work

Leica consistently joins as a specialist participant or third party rather than leading consortia — zero coordinator roles across all four projects. They work in large, multi-country consortia (68 unique partners across 16 countries), which is typical for an equipment manufacturer providing technology to diverse research groups. Their value proposition is clear: they bring the instruments, others bring the science.

Extensive European network spanning 68 unique partners across 16 countries, built through participation in large research and training consortia. Their reach is broad rather than concentrated in any single region, consistent with a global instrumentation company.

What sets them apart

Unlike academic imaging labs, Leica brings commercially available, production-grade microscopy systems to consortia — meaning project results can translate directly into products that other labs can purchase and replicate. They bridge the gap between experimental imaging setups and deployable instruments. For consortium builders, including Leica signals that the imaging technology developed in the project has a pathway to broad adoption beyond the consortium itself.

Highlights from their portfolio

• 4DHeart
  Largest funded project (EUR 249,216) combining light sheet microscopy with optical tweezers for 4D cardiac imaging — a strong showcase of their core capabilities.
• MUSIQ
  Represents their frontier direction: merging multiphoton microscopy with ultrafast spectroscopy and quantum-level light-matter interactions, signaling expansion beyond classical microscopy.
• RenalToolBox
  Demonstrates application of their imaging tech to regenerative medicine (stem cell tracking in kidney disease), showing versatility beyond basic research.